InnoCan Pharma's total assets for Q3 2024 were $9.60M, an increase of 10.08% from the previous quarter. TSE:INNO total liabilities were $2.65M for the fiscal quarter, a -0.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.